SUZHOU, China — Registration is officially open for BIOCHINA 2027, one of the premier healthcare and life sciences conventions in Asia, returning to Suzhou, China from March 10–12, 2027. Attendees who register by December 31, 2026, can secure an exclusive 10% Early Bird discount across all pass types before standard pricing takes effect.

As cross-border collaboration and biopharma innovation continue to accelerate, BIOCHINA 2027 offers an unparalleled platform for global biotech companies, pharmaceutical leaders, CROs/CDMOs, and investment funds to connect, collaborate, and drive next-generation healthcare deals.

Why Attend BIOCHINA 2027?

BIOCHINA 2027 is structured to foster impactful face-to-face engagements and showcase cutting-edge innovations across the life sciences value chain:

• Curated 1-on-1 Partnering: Access pre-scheduled, targeted meetings with potential business development partners, licensors, and investors aligned with your clinical pipeline.
• World-Class Forum: Gain strategic insights over three days of high-level keynotes, panel discussions, and technical tracks led by global biopharma leaders and emerging innovators.
• Full Exhibition Access: Explore a dynamic show floor showcasing state-of-the-art technologies, research platforms, and manufacturing solutions reshaping the industry.
• Global Networking: Connect with executives, BD delegates, and venture capitalists representing top international biopharma hubs.

Registration & Early Bird Savings

The 10% Early Bird discount applies to all ticket tiers—including Partnering Passes, General Passes, and Exhibition Passes—through December 31, 2026.

• Event Dates: March 10–12, 2027
• Location: Suzhou, China
• Early Bird Deadline: December 31, 2026
• Official Website: www.biocn.cn/en/en.html
• Register Now: https://u.morebio.cn/yQvMJntQ

To explore more about BIOCHINA updates and global community highlights, visit the official LinkedIn Announcement.